Company Number: 15108058

Analysis Date: 2025-07-20 14:47 UTC

1. Credit Opinion: APPROVE with conditions. Ryan Thomas Podiatry Limited is a newly incorporated private limited company with a small but positive net asset position and modest working capital. The company is operating in the healthcare sector with a sole director and owner, Mr. Ryan O'Reilly, who is also the practicing podiatrist. Given the company's early stage and limited financial history, approval should be conditional on ongoing monitoring of cash flow and profitability, and confirmation of sustained trading activity.

2. Financial Strength: The company reports net assets of £2,377 as of 31 August 2024, supported by current assets of £5,962 (all cash) against current liabilities of £3,585. The balance sheet is very modest, reflecting the micro company size with only one employee (the director). There are no fixed assets recorded, indicating no significant capital investment yet. Shareholders' funds of £2,377 primarily consist of retained earnings and the initial share capital of £100. The small equity base and absence of tangible assets imply limited financial buffer to absorb shocks.

3. Cash Flow Assessment: The £5,962 cash balance provides a reasonable liquidity cushion relative to current liabilities of £3,585, resulting in positive net current assets of £2,377. This suggests the company can meet short-term obligations presently. However, being a single-person operation with a small cash base, liquidity could quickly become strained if revenue generation is not consistent or if unexpected expenses arise. Close attention should be paid to cash flow statements in future filings to track operational cash generation.

4. Monitoring Points:

• Revenue growth and profitability trends in subsequent accounting periods to ensure sustainability.
• Cash flow adequacy to cover liabilities and any potential working capital needs.
• Changes in current liabilities and creditor payment terms.
• Any additional capital injections or borrowings that might affect leverage.
• Confirmation that director’s management remains active and compliant with filing deadlines.